Smith & Nephew (SNN) Cash & Current Investments (2009 - 2025)

Smith & Nephew (SNN) posted quarterly Cash & Current Investments of $577.0 million for Q4 2025, down 13.36% year-on-year from $666.0 million in Q4 2024, and down 14.64% on a QoQ basis from $676.0 million in Q2 2025.

Smith & Nephew (SNN) Cash & Current Investments (2009 - 2025) Analysis & Trends

Smith & Nephew (SNN) has reported Cash & Current Investments for 17 consecutive years, with $577.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Cash & Current Investments fell 13.36% year-over-year to $577.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $577.0 million (down 13.36% YoY) and the FY2025 annual result came in at $577.0 million, down 13.36% from the prior year.
  • Cash & Current Investments eased to $577.0 million in Q4 2025 per SNN's latest filing, from $676.0 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for SNN reached as high as $1.3 billion in Q4 2021 and fell as low as $329.0 million in Q4 2023.
  • A 5-year average of $648.9 million and a median of $577.0 million in 2025 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 70.13% — and 2024, when it soared 102.43%.
  • Year by year, Cash & Current Investments stood at $1.3 billion in 2021, then tumbled by 70.13% to $397.0 million in 2022, then dropped by 17.13% to $329.0 million in 2023, then soared by 102.43% to $666.0 million in 2024, then dropped by 13.36% to $577.0 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $577.0 million, $676.0 million, and $666.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 7.30 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 2.88 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 577.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.12 Bn
10 Steris 21.47 Bn 21.03 Bn 697.10 Mn 439.60 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 577.00 Mn
Jun 28, 2025 676.00 Mn
Dec 31, 2024 666.00 Mn
Jun 29, 2024 568.00 Mn
Dec 31, 2023 329.00 Mn
Dec 31, 2022 397.00 Mn
Dec 31, 2021 1.33 Bn
Dec 31, 2020 1.79 Bn
Jun 30, 2020 347.00 Mn
Dec 31, 2019 283.00 Mn
Jun 29, 2019 137.00 Mn
Dec 31, 2018 370.00 Mn
Jun 30, 2018 99.00 Mn
Dec 31, 2017 183.00 Mn
Dec 31, 2016 86.00 Mn
Dec 31, 2015 135.00 Mn
Jun 30, 2015 88.00 Mn
Dec 31, 2014 65.00 Mn
Sep 30, 2014 147.00 Mn
Jun 28, 2014 140.00 Mn